Dosage reference for how many boxes of capmatinib (Touradda) you need to take in a month

Capmatinib (Capmatinib) is an oral METtyrosine kinase inhibitor, mainly used to treat patients with MET exon 14 skipping mutations in non-small cell lung cancer (NSCLC). The standard recommended dose is 400mg, taken twice a day continuously. Based on the calculation of 400mg each time and twice a day, the patient needs to take 800mg of the drug every day to achieve the blood drug concentration required for clinical treatment.

The common packaging specification of capmatinib on the market is 200mg capsules, and each box usually contains 60 capsules. According to standard dose calculation, patients need to take 4 capsules every day (400mg×2 times/200mg capsules), each box of medicine can be used for approximately 14 days. In other words, a one-month (approximately 30 days) treatment cycle requires approximately 2 boxes of medication to meet daily medication needs.

It should be noted that the actual dosage may be adjusted based on the patient's weight, liver and kidney function, and concomitant medications. If the patient develops intolerance or adverse drug reactions, the doctor may adjust the dosage appropriately, reduce the number of capsules per day or extend the dosage interval, thereby affecting the amount of medication required for a month. Therefore, the specific dosage should strictly follow the doctor's individualized medication plan.

In addition, patients should pay attention to drug storage and regular use during medication, and avoid missing or repeated medication. For patients undergoing long-term treatment, it is recommended to prepare sufficient dosage in advance, maintain communication with the doctor, and promptly evaluate the efficacy and side effects. By scientifically managing the dosage, we can ensure that capmatinib is effective in treating METexon14skipping mutationsNSCLCto achieve the best results in patients.

Reference link:https://www.drugs.com